Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

uch patients are characterized by presence of chromosomal abnormalities (i.e., deletions of chromosome 17p or 11q) or short remissions (less than 3 years) after standard chemo-immunotherapy. To develop an alternative therapy regimen for this patient population, researchers explored the combination of ibrutinib and the anti-CD20 antibody rituximab in high-risk CLL.

In this Phase II study conducted at The University of Texas MD Anderson Cancer Center in Houston, ibrutinib was given in combination with rituximab to evaluate its potential to accelerate and improve CLL patient responses. Forty patients were treated with 420 mg of ibrutinib daily in combination with weekly rituximab for four weeks, followed by ibrutinib daily plus monthly rituximab until month six, followed by single-agent ibrutinib.

Positive responses to therapy were shown among the vast majority of treated patients. At four months of follow-up, the overall response rate was 85 percent and almost all (38 of 40) patients continued on therapy without disease progression. Of the 20 patients evaluable for early response, 17 achieved a partial remission. Patient health questionnaires also noted improvements in health and the quality of life of all treated patients.

Overall, the regimen was well-tolerated among participants, with little severe toxicity that was largely unrelated and short in duration. After treatment with ibrutinib-rituximab (iR) combination therapy, most cases of early lymphocytosis (increase in white blood cells that is a sign of infection), due to the ibrutinib-induced shift of CLL cells from lymph node tissues into the blood, peaked early and resolved; at four months of follow-up, only three treated patients had lymphocytosis that had not yet resolved. This shorter lymphocytosis duration, when compared to single-agent use of ibrutinib, is presumably related to the addition of rituximab.

"We know that high-risk CLL patients struggle with the effects of
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , ... July 06, 2015 , ... The Path of ... into the economic transformation associated with the U.S. economy over the past 40 years. ... with its use. In many ways, the book is a time capsule that chronicles ...
(Date:7/5/2015)... ... July 05, 2015 , ... World Patent Marketing, a vertically ... invention that effectively removes weeds without harming man and nature. , "The ... and Creative Director of World Patent Marketing. "It is projected to grow at ...
(Date:7/4/2015)... Florida (PRWEB) , ... July 04, 2015 , ... ... of Plastic Surgeons published the results of an annual member survey , ... the United States. More recently, the group broke that raw data down into ...
(Date:7/3/2015)... ... July 04, 2015 , ... The Harvest Hope Food Bank will hopefully be getting ... AlignLife offices in the area of Greenville SC are making it their mission to ... patients only. They are asking for donations from the public as well. As part of ...
(Date:7/3/2015)... ... July 03, 2015 , ... Scientists at several top US cancer centers ... minimal asbestos exposure. Click here to read the complete story , just posted ... Center, Cedars Sinai Medical Center, and New York University exposed mice with a mutation ...
Breaking Medicine News(10 mins):Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 2Health News:Greenville Area AlignLife Offices to do a Thanksgiving in July Food Drive 3Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2
... a subsidiary of MGT Capital Investments, Inc. (NYSE-A: ... of Computer-Aided Detection (CAD) and image analysis software, ... disease, today announces the following restructuring of its ... currently Chief Financial Officer, becomes Chief Executive Officer; ...
... Bill Would Create National Patient Registry, Increase Public ... The Coalition for Pulmonary Fibrosis (CPF) is excited ... pulmonary fibrosis (PF) advocacy program -- the introduction ... 2009 (PFREA) in the 111th Congress. The PFREA, ...
... beneath the ocean,s surface, tiny phytoplankton swimming upward in ... watery equivalent of Rod Serling,s Twilight Zone: a sharp ... single-celled organisms and sends them tumbling until a shift ... them free. , Scientists are aware of these ...
... Crestline Custom Imprinted Products, a direct marketing promotional products company, ... items. , ... Lewiston, ME (PRWEB) ... marketing promotional products company that trades on its ...
... a Use Not Approved By the Food and Drug ... in two whistleblower suits filed in the Northern District ... its parent company, Johnson & Johnson Inc., alleging that ... use not approved by the Food and Drug Administration ...
... a 40% Reduction of Intraocular Pressure at Two Years ... that it has surpassed 1000 implantation procedures with its ... intraocular pressure (IOP) for the treatment of glaucoma. ... and Founder of SOLX, "as it validates the importance ...
Cached Medicine News:Health News:Medicsight PLC Restructures Management Team 2Health News:Medicsight PLC Restructures Management Team 3Health News:Pulmonary Fibrosis Research Enhancement Act of 2009 Introduced in 111th U.S. Congress 2Health News:Pulmonary Fibrosis Research Enhancement Act of 2009 Introduced in 111th U.S. Congress 3Health News:Pulmonary Fibrosis Research Enhancement Act of 2009 Introduced in 111th U.S. Congress 4Health News:MIT research could help predict red tide 2Health News:MIT research could help predict red tide 3Health News:Crestline is the Source for Great Green Giveaways 2Health News:Crestline is the Source for Great Green Giveaways 3Health News:United States Joins Suits Against Scios and Johnson & Johnson 2Health News:United States Joins Suits Against Scios and Johnson & Johnson 3Health News:SOLX Announces 1000th Gold Shunt Implantation Milestone for Glaucoma Treatment 2
(Date:7/4/2015)... July 4, 2015 ... eerstelijns chemotherapie voor patiënten met niet-resectabele uitgezaaide ... de progressievrije overleving in dat orgaan. ... kanker (mCRC) die alleen binnen de lever ... progressievrije overleving (PFS) in de lever dankzij ...
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... NEW YORK , July 3, 2015  Obsidian ... ) - an online service for the management of ... professionals announced today that PharmaShine now includes the 2014 ... Center for Medicare Services on June 30. The data ... 11.4 million transactions between industry and providers totaling $6.49 ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2
... Pittsburgh -based Foundation Radiology Group (FRG), a premier provider ... strategic partnership with Acusis, a national provider of outsourced medical transcription ... , , ... Acusis delivers healthcare solutions that are designed to improve the productivity ...
... SHENZHEN, China , July 20 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International ... of medical devices worldwide, today announced that it will report its,financial ... after the U.S.,market closes on August 9, 2010 . Mindray,s ... on August 10, 2010 U.S. Eastern Time ( 8:00 ...
Cached Medicine Technology:Foundation Radiology Group Forms Strategic Partnership with Transcription Experts, Acusis 2Foundation Radiology Group Forms Strategic Partnership with Transcription Experts, Acusis 3Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010 2Mindray to Report Second Quarter 2010 Financial Results on August 9, 2010 3
... Oscors proprietary quadripolar pacing wire ... pacing and sensing in the ... two bipolar wires in one ... the atrium and ventricle are ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: